Home539730 • BOM
add
Fredun Pharmaceuticals Ltd
Previous close
₹1,043.50
Day range
₹1,016.20 - ₹1,065.95
Year range
₹635.00 - ₹1,143.00
Market cap
4.94B INR
Avg Volume
22.30K
P/E ratio
20.10
Dividend yield
-
Primary exchange
BOM
Market news
NFLX
0.68%
0.29%
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 1.20B | 52.08% |
Operating expense | 162.24M | 89.85% |
Net income | 67.66M | 63.82% |
Net profit margin | 5.64 | 7.63% |
Earnings per share | — | — |
EBITDA | 168.32M | 62.36% |
Effective tax rate | 25.16% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 59.73M | 176.77% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.41B | — |
Shares outstanding | 4.72M | — |
Price to book | 3.25 | — |
Return on assets | — | — |
Return on capital | 12.62% | — |
Cash Flow
Net change in cash
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 67.66M | 63.82% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1987
Website
Employees
256